Press releases

Read more:

Search
Categories

2025

Nanologica has received an order for a non-silica-based purification media from a customer in Asia. The order value amounts to approximately SEK 1.5 million...
2025-10-23 08:10 Interim Report Q3 2025 Nanologica AB (publ) Regulatory
FINANCIAL SUMMARY EVENTS DURING THE THIRD QUARTER EVENTS AFTER THE END OF THE PERIOD COMMENT FROM THE CEOWith stable production and a first order on the...
Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order...
Nanologica has received a supplementary order for the company's silica-based purification media NLAB Saga® from a customer in the US who placed...
In accordance with the current nomination committee instructions, the chairman of the board has contacted Nanologica's three largest shareholders...
Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media...
2025-07-10 08:10 Interim Report Q2 2025 Nanologica AB (publ) Regulatory
FINANCIAL SUMMARY EVENTS DURING THE SECOND QUARTER CEO COMMENTAs expected, the second quarter was not as strong in terms of sales as the first. However...
The number of registered shares and votes in Nanologica AB has changed during the month of June following the registration of exercised warrants of series...
The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") unanimously recommends the shareholders of Nanologica...
Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new customer in the US. The customer is a...